Publicly Funded Vaccines

This information is for pharmacists who are authorized to administer publicly funded vaccines.

PharmaCare pays a fee for publicly funded vaccines only when a pharmacist administers the vaccine by injection to B.C. residents who meet the eligibility criteria. See the B.C. Immunization Manual for the criteria, immunization schedule and other important information.

Vaccines must be administered by an authorized pharmacist. Vaccinations provided by other healthcare professionals, such as nurses hired for pharmacy clinics, cannot be claimed.

For administering publicly funded vaccines to eligible patients:

  • Use the appropriate PIN (whether or not the product is eligible for an injection fee)
  • Enter the quantity as the fluid volume of the vaccine (e.g., 0.5 mL)
  • Do not enter a drug cost or fee
  • No intervention code is needed for vaccine administration fee claims. You do not need to enter the DE intervention code* to ensure the patient is not charged. If the DE intervention code has been entered, the vaccination administration fee will still be paid


For administering a vaccine to patients who are not eligible for publicly funded vaccines:

  • Dispense the vaccine ordered from your private supplier
  • Use the product’s DIN
  • Charge the patient directly

Important: Record the lot number for every vaccine administered to each patient in your pharmacy records. Recording vaccine lot numbers is required in case of rare events such as a vaccine recall or an adverse event following immunization (AEFI).

COVID-19 vaccine PINs

The BCPhA, with the Ministry of Health, has created a guide with details about PharmaNet data entry (unique to the COVID-19 vaccine), inventory tracking using your office use medication PHN (O-Med), cold-chain reporting, reimbursement, after-care and how to manage and report adverse events following immunization (AEFI), how to prevent and report wastage, and other details essential to pharmacies administering the vaccine.

For guidelines for an informed-consent conversation with a client and a health assessment before administering a vaccine, please see the BCCDC's COVID19 vaccine screening checklist (PDF).

Additional information is in the BC Immunization Manual, Part 4 – Biological Products, COVID-19 vaccines.

C-19 Vaccine 2
Vaccine Product Group Brand Vaccine Product PIN


Manufacturer: AstraZeneca

COVID-19 Vaccine (ChAdOx1-S [recombinant])


Applies to both 8-dose and 10-dose vials

Seasonal influenza PINs (2021-2022)

Pharmacists may offer a publicly funded influenza vaccine to eligible B.C. residents as soon as it becomes available in their community. For information on when supplies will be made available, consult your local health unit or health authority. PINs for seasonal influenza vaccination claims submissions are effective September 1, 2021 until June 1, 2022.

Note: Seasonal flu vaccine PINs are only active between September 1 and June 1 of each year.

Inclusion of a product in the lists below does not guarantee that the product is available. 

Seasonal influenza vaccines
Vaccine Product Group Vaccine Product PIN
Afluria® Tetra Quadrivalent  66127355
Flulaval® Tetra 66128005
FluMist® Quadrivalent 66128276
Fluzone® High-Dose (Quadrivalent) 66127356
Fluzone® Quadrivalent 66128073

Other vaccine PINs

Other vaccines
Vaccine Product Group Vaccine Product PIN
Haemophilus b conjugate Act-HIB® 66128205
Haemophilus influenzae type b conjugate Hiberix® 66128170
Hepatitis A Avaxim 66124760
Avaxim Pediatric 66124831
Havrix® 1440 66124768
Havrix® Junior 720 66124769
Vaqta® Adult 66124794
Vaqta® Pediatric 66124795
Hepatitis B Engerix® B 66124764
Engerix® B Pediatric 66128130
Recombivax HB® 66124789
Recombivax HB® Adult Dialysis 66124790
Recombivax HB® Pediatric 66124791
Human papillomavirus (2 strains) Cervarix™ 66127902
Human papillomavirus (9 strains) Gardasil® 9 66128117
Measles, mumps, rubella MMR-II 66124781
Priorix 66124834
Measles, mumps, rubella, and varicella virus Proquad® 66128068
Priorix-Tetra 66128069
Meningococcal group B Bexsero 66128075
Meningococcal C conjugate Meningitec 66124832
Menjugate® 66128114
Neis Vac-C® 66124782
Pneumococcal conjugate 13-valent Prevnar 13 66128070
Pneumococcal 23-valent Pneumovax® 23 66124785
IPV (polio for travel indications) Imovax® Polio 66124773
Quadrivalent meningococcal conjugate Menveo 66128071
Menactra 66128072
Nimenrix® 66128152
Rabies RabAvert® 66124788
Tetanus, diphtheria Td Adsorbed 66124793
Tetanus, diphtheria, acellular pertussis Adacel® 66124758
Boostrix® 66127901
Tetanus, diphtheria, acellular pertussis, polio adsorbed Quadracel® 66124787
Adacel® Polio 66128131
Boostrix®-Polio 66128094
Tetanus, diphtheria, acellular pertussis, polio, hepatitis B, haemophilus influenzae type b adsorbed Infanrix hexa® 66124776
Tetanus, diphtheria, IPV (polio for travel indications) Td Polio Adsorbed 66124792
Varicella Varilrix® 66124796
Varivax® III 66124797